Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy

Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy is a phase 2, randomised interventional study registered as NCT07201519 by Michael J Cavnar, MD, with a registry enrolment figure of 80 participants, started 2026-01-23 and due to reach its primary completion in 2028-02. Interventions recorded: Hepatic Artery Infusion Pump (HAIP); Standard Treatment; Community Treatment; Systemic Chemotherapy Standard of Care; Standard Of Care targeting driver mutations. Conditions listed: Colorectal Cancer Metastatic; Intrahepatic Cholangiocarcinoma. Primary outcome: Percent of participants with HAI Pump still in use at 3 months. Colorectal eligibility wording from the registry: "* Colorectal adenocarcinoma metastatic to the liver which is either Unresectable (group A) or Resectable (group B; ie, will be completely resected), AND with no definitive clinical or radiographic evidence of extrahepatic disease other than: metastatic disease to resectable peri-hepatic lymph nodes;". Sites: United States. No results are recorded here; the registry entry is the source.